Bacterial infections of the central nervous system: A critical role for resident glial cells in the initiation and progression of inflammation

Current Immunology Reviews

Volumn 3, Issue 2, 2007, Pages 133-143

  Chauhan, Vinita S ^a   Marriott, Ian ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Astrocytes; Bacteria; CNS; Inflammation; Microglia

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CELL SURFACE PROTEIN; CHEMOKINE; CXCL1 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; PROTEIN ZO1; RANTES; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN SPECIFICITY; ASTROCYTE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIUM CONTAMINATION; BLOOD BRAIN BARRIER; BRAIN ABSCESS; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENCEPHALITIS; GLIA CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTOSIS; MICROGLIA; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 34249722703     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339507780655496     Document Type: Review

References (159)

1. Rajnik M, Ottolini MG. Serious infections of the central nervous system: encephalitis, meningitis, and brain abscess. Adolesc Med 2000; 11: 401-25.
2. Sundaram, C, Lakshmi V. Pathogenesis and pathology of brain abscess. Indian J Pathol Microbiol 2006; 49: 317-26.
3. Karampekios S, Hesselink J. Cerebral infections. Eur Radiol 2005; 15: 485-93.
4. Bailey SL, Carpentier PA, McMahon EJ, Begolka WS, Miller SD. Innate and adaptive immune responses of the central nervous system. Crit Rev Immunol 2006; 26: 149-88.
5. Anslow P. Cranial bacterial infection. Eur Radiol 2004; 14: E145-54.
6. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 1995; 20: 269-87.
7. Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 1999; 58: 233-47.
8. Spach DH, Jackson LA. Bacterial meningitis. Neurol Clin 1999; 17: 711-35.
9. Lewis P, Glaser CA. Encephalitis. Pediatr Rev 2005; 26: 353-63.
10. Koedel U, Pfister HW. Models of experimental bacterial meningitis. Role and limitations. Infect Dis Clin North Am 1999; 13: 549-77
11. Mathisen GE, Johnson JP. Brain abscess. Clin Infect Dis 1997; 25: 763-79
12. Calfee DP, Wispelwey B. Brain abscess. Semin Neurol 2000; 20: 353-60.
13. Twomey CR. Brain abscess: an update. J Neurosci Nuts 1992; 24: 34-9.
14. Wispelwey B, Scheld WM. Brain abscess. Semin Neurol 1992; 12: 273-8.
15. Kim KS. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 2003; 4: 376-85.
16. Kim KS. Emerging molecular targets in the treatment of bacterial meningitis. Expert Opin Ther Targets 2003; 7: 141-52.
17. Koskiniemi M, Korppi M, Mustonen K, et al. Epidemiology of encephalitis in children. A prospective multicentre study. Eur J Pediatr 1997; 156: 541-5.
18. Beghi E, Nicolosi A, Kurland LT, Mulder DW, Hauser WA, Shuster L. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Epidemiology. Ann Neurol 1984; 16: 283-94.
19. Bitnum A, Ford-Jones EL, Petric M, et al. Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis 2001; 32: 1674-84.
20. Menaker J, Martin IB, Hirshon JM. Marked elevation of cerebrospinal fluid white blood cell count: an unusual case of Streptococcus pneumoniae meningitis, differential diagnosis, and a brief review of current epidemiology and treatment recommendations. J Emerg Med 2005; 29: 37-41
21. Koedel U, Scheld WM, Pfister HW. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002; 2: 721-36.
22. Tunkel AR, Scheld WM. Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev 1993; 6(2): 118-36.
23. Brook I. Brain abscess in children: microbiology and management. J Child Neurol. 1995; 10: 283-8.
24. Tuomanen E. Entry of pathogens into the central nervous system. FEMS Microbiol Rev 1996; 18: 289-99.
25. Persidsky Y. Model systems for studies of leukocyte migration across the blood brain barrier. J Neurovirol 1999; 5: 579-90.
26. Kim KS. Microbial translocation of the blood-brain barrier. Int J Parasitol 2006; 36: 607-14.
27. Wekerle H. Breaking ignorance: the case of the brain. Curr Top Microbiol Immunol 2006; 305: 25-50.
28. Sehgal A, Berger MS. Basic concepts of immunology and neuroimmunology. Neurosurg Focus 2000; 9: e1.
29. Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunol Rev 2006; 213: 48-65.
30. Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R, Frei K. Molecular and cellular permeability control at the blood-brain barrier. Brain Res Brain Res Rev 2001; 36: 258-64.
31. Nassif X, Bourdoulous S, Eugene E, Couraud PO. How do extracellular pathogens cross the blood-brain barrier? Trends Microbiol 2002; 10: 227-32.
32. Rieckmann P, Engelhardt B. Building up the blood-brain barrier. Nat Med 2003; 9: 828-9.
33. Deli MA, Abraham CS, Kataoka Y, Niwa M. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 2005; 25: 59-127.
34. Doran KS, Engelson EJ, Khosravi A, et al. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest 2005; 115: 2499-507.
35. Drevets DA, Leenen PJ, Greenfield RA. Invasion of the central nervous system by intracellular bacteria. Clin Microbiol Rev 2004; 17: 323-47.
36. Nassif X. Interaction mechanisms of encapsulated meningococci with eucaryotic cells: what does this tell us about the crossing of the blood-brain barrier by Neisseria meningitidis? Cuff Opin Microbiol 1999; 2: 71-7.
37. Nassif X. Interactions between encapsulated Neisseria meningitidis and host cells. Int Microbiol 1999; 2: 133-6.
38. Shin S, Lu G, Cai M, Kim KS. Escherichia coli outer membrane protein A adheres to human brain microvascular endothelial cells. Biochem Biophys Res Commun 2005; 330:1199-204.
39. Boveri M, Kinsner A, Berezowski V, et al. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience 2006; 137: 1193-209.
40. Nikulin J, Panzner U, Frosch M, Schubert-Unkmeir A. Intracellular survival and replication of Neisseria meningitidis in human brain microvascular endothelial cells. Int J Med Microbiol 2006; 296: 553-8.
41. Johansson L, Rytkonen A, Bergman P, et al. CD46 in meningococcal disease. Science 2003; 301: 373-5.
42. Johansson L, Rytkonen A, Wan H, et al. Human-like immune responses in CD46 transgenic mice. J Immunol 2005; 175: 433-40.
43. Shin S, Lu G, Cai M, Kim KS. Escherichia coli outer membrane protein A adheres to human brain microvascular endothelial cells. Biochem Biophys Res Commun 2005; 330: 1199-204.
44. Kim KS. Escherichia coli translocation at the blood-brain barrier. Infect Immun 2001; 69: 5217-22.
45. Xie Y, Kim KJ, Kim KS. Current concepts on Escherichia coli K1 translocation of the blood-brain barrier. FEMS Immunol Med Microbiol 2004; 42: 271-9.
46. Plant L, Sundqvist J, Zughaier S, Lovkvist L, Stephens DS, Jonsson AB. Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis. Infect Immun 2006; 74: 1360-7.
47. Grab DJ, Perides G, Dumler JS, et al. Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect Immun 2005; 73: 1014-22.
48. Halperin JJ. Neuroborreliosis. Am J Med 1995; 98: 52S-56S.
49. Kaiser R. Neuroborreliosis. J Neurol 1998; 245: 247-55.
50. Halperin JJ. Nervous system Lyme disease. J Neurol Sci 1998; 153: 182-91.
51. Behling-Kelly E, Vonderheid H, Kim KS, Corbeil LB, Czuprynski CJ. Roles of cellular activation and sulfated glycans in Haemophilus sommus adherence to bovine brain microvascular endothelial cells. Infect Immun 2006; 74: 5311-8.
52. Vanier G, Szezotka A, Friedl P, Lacouture S, Jacques M, Gottschalk M. Haemophilus parasuis invades porcine brain microvascular endothelial cells. Microbiology 2006; 152: 135-42.
53. Kim KS, Wass CA, Cross AS. Blood-brain barrier permeability during the development of experimental bacterial meningitis in the rat. Exp Neurol 1997; 145: 253-7.
54. Drevets DA, Leenen PJ. Leukocyte-facilitated entry of intracellular pathogens into the central nervous system. Microbes Infect 2000; 2: 1609-18.
55. MacIntyre A, Abramov R, Hammond CJ, et al. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J Neurosci Res 2003; 71: 740-50.
56. Lecuit M. Understanding how Listeria monocytogenes targets and crosses host barriers. Clin Microbiol Infect 2005; 11: 430-6.
57. Sousa S, Lecuit M, Cossart P. Microbial strategies to target, cross or disrupt epithelia. Curr Opin Cell Biol 2005; 17: 489-98.
58. Lecuit M, Dramsi S, Gottardi C, Fedor-Chaiken M, Gumbiner B, Cossart P. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J 1999; 18: 3956-63.
59. Davies DC. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 2002; 200: 639-46.
60. Krizanac-Bengez L, Kapural M, Parkinson F, et al. Effects of transient loss of shear stress on blood-brain barrier endothelium: role of nitric oxide and IL-6. Brain Res 2003; 977: 239-46.
61. Pachner AR, Amemiya K, Delaney E, O'Neill T, Hughes CA, Zhang WF. Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology 1997; 49: 147-52.
62. Sjowall J, Carlsson A, Vaarala O, et al. Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes. Clin Exp Immunol 2005; 141: 89-98.
63. Sternberg EM. Neural-immune interactions in health and disease. J Clin Invest 1997; 100: 2641-7.
64. Tsao N, Hsu HP, Wu CM, Liu CC, Lei HY. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol 2001; 50: 812-21.
65. Widhe M, Skogman BH, Jarefors S, et al. Up-regulation of Borrelia-specific IL-4- and IFN-gamma-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis. Int Immunol 2005; 17: 1283-91.
66. Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A. Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol 1998; 85: 33-43.
67. Neumann H. Control of glial immune function by neurons. Glia 2001; 36: 191-9.
68. Rock RB, Gekker G, Hu S, et al. Role of microglia in central nervous system infections. Clin Microbiol Rev 2004; 17: 942-64.
69. Kielian T. Microglia and chemokines in infectious diseases of the nervous system: views and reviews. Front Biosci 2004; 9: 732-50.
70. Aloisi F. Immune function of microglia. Glia 2001; 36:165-79. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004; 173: 3916-24.
71. Streit WJ, Kincaid-Colton CA. The brain's immune system. Sci Am 1995; 273: 54-5, 58-61.
72. Graeber MB, Streit WJ. Microglia: immune network in the CNS. Brain Pathol 1990; 1: 2-5.
73. Streit WJ, Graeber MB, Kreutzberg GW. Functional plasticity of microglia: a review. Glia 1988; 1: 301-7.
74. Pennell NA, Streit WJ. Tracing of fluoro-gold prelabeled microglia injected into the adult rat brain. Glia 1998; 23: 84-8
75. Rasley A, Anguita J, Marriott I. Borrelia burgdorferi induces inflammatory mediator production by murine microglia. J Neuroimmunol 2002; 130: 22-31.
76. Rasley A, Marriott I, Halberstadt CR, Bost KL, Anguita J. Substance P augments Borrelia burgdorferi-induced prostaglandin E2 production by murine microglia. J Immunol 2004; 172: 5707-13.
77. Rasley A, Tranguch SL, Rati DM, Marriott I. Murine glia express the immunosuppressive cytokine, interleukin-10, following exposure to Borrelia burgdorferi or Neisseria meningitidis. Glia 2006; 53: 583-92.
78. Garcia-Monco JC, Benach JL. Mechanisms of injury in Lyme neuroborreliosis. Semin Neurol 1997; 17: 57-62.
79. Isogai E, Isogai H, Kimura K, et al. Cytokines in the serum and brain in mice infected with distinct species of Lyme disease Borrelia. Microb Pathog 1996; 21: 413-9.
80. Esen N, Kielian T. Central role for MyD88 in the responses of microglia to pathogen-associated molecular patterns. J Immunol 2006; 176: 6802-11.
81. Esen N, Kielian T. Recognition of Staphylococcus aureus-derived peptidoglycan (PGN) but not intact bacteria is mediated by CD14 in microglia. J Neuroimmunol 2005; 170: 93-104.
82. Baldwin AC, Kielian T. Persistent immune activation associated with a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuroimmunol 2004; 151: 24-32.
83. Kielian T, Esen N, Bearden ED. Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia. Glia 2005; 49: 567-76.
84. Dong Y, Benveniste EN. Immune function of astrocytes. Glia 2001; 36: 180-90.
85. Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 2005; 49: 360-74.
86. Brabers NA, Nottet HS. Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest 2006; 36: 447-58.
87. Kielian T, Hickey WF. Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. Am J Pathol 2000; 157: 647-58.
88. Lee YJ, Panek RB, Huston M, Benveniste EN. Role of protein kinase C and tyrosine kinase activity in IFN-gamma-induced expression of the class II MHC gene. Am J Physiol 1995; 268: C127-37.
89. Dong Y, Benveniste EN. Immune function of astrocytes. Glia 2001; 36: 180-90.
90. Xiao BG, Link H. Immune regulation within the central nervous system. J Neurol Sci 1998; 157: 1-12.
91. Frohman EM, van den Noort S, Gupta S. Astrocytes and intracerebral immune responses. J Clin Immunol 1989; 9: 1-9.
92. Mossner R, Sedgwick J, Flory E, Korner H, Wege H, ter Meulen V. Astrocytes as antigen presenting cells for primary and secondary T cell responses: effect of astrocyte infection by murine hepatitis virus. Adv Exp Med Biol 1990; 276: 647-54.
93. Hirayama M, Miyadai T, Yokochi T, et al. Infection of human T-lymphotropic virus type I to astrocytes in vitro with induction of the class II major histocompatibility complex. Neurosci Lett 1988; 92: 34-9.
94. Ramesh G, Philipp MT. Pathogenesis of Lyme neuroborreliosis: mitogen-activated protein kinases Erk1, Erk2, and p38 in the response of astrocytes to Borrelia burgdorferi lipoproteins. Neurosci Lett 2005; 384: 112-6.
95. Kielian T, Bearden ED, Baldwin AC, Esen N. IL-1 and TNF-alpha play a pivotal role in the host immune response in a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuropathol Exp Neurol 2004; 63: 381-96.
96. Esen N, Tanga FY, DeLeo JA, Kielian T. Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram-positive bacterium Staphylococcus aureus. J Neurochem 2004; 88: 746-58.
97. Rock RB, Hu S, Gekker G, et al. Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone. J Infect Dis 2005; 192: 2054-8.
98. Granert C, Rand J, Waage A, Lindquist L. Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit. Infect Immun 1999; 67: 2071-4.
99. Prinz M, Kann O, Draheim HJ, et al. Microglial activation by components of gram-positive and -negative bacteria: distinct and common routes to the induction of ion channels and cytokines. J Neuropathol Exp Neurol 1999; 58: 1078-89.
100. Ramesh G, Alvarez AL, Roberts ED, el al. Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. Eur J Immunol 2003; 33: 25 39-50.
101. Saito H, Tomioka H, Sato K, Watanabe T. Abilities of human oligodendroglial cells and mouse Schwann cells to phagocytose Mycobacterium leprae and other mycobacteria. Infect Immun 1986; 51: 157-62.
102. Wu HH, Hsieh WS, Yang YY, Tsai MC. Lipoteichoic acid induces prostaglandin E(2) release and cyclooxygenase-2 synthesis in rat cortical neuronal cells: involvement of PKCepsilon and ERK activation. Life Sci 2006; 79: 272-80.
103. Bowman CC, Rasley A, Tranguch SL, Marriott I. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003; 43: 281-91.
104. McKimmie CS, Fazakerley JK. In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J Neuroimmunol 2005; 169: 116-25.
105. Cassiani-Ingoni R, Cabral ES, Lunemann JD, et al. Borrelia burgdorferi Induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-class II expression. J Neuropathol Exp Neurol 2006; 65: 540-8.
106. Lehnardt S, Henneke P, Lien E, et al. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol 2006; 177: 583-92.
107. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002; 61: 1013-21
108. Jack CS, Arbour N, Manusow J, et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005; 175: 4320-30.
109. Zhou H, Lapointe BM, Clark SR, Zbytnuik L, Kubes P. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J Immunol 2006; 177: 8103-10.
110. Bsibsi M, Persoon-Deen C, Verwer RW, Meeuwsen S, Ravid R, Van Noort M. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 2006; 53: 688-95
111. Konat GW, Kielian T, Marriott I. The role of Toll-like receptors in CNS response to microbial challenge. J Neurochem 2006; 99: 1-12.
112. Kielian T. Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 2006; 83: 711-30.
113. Lee SJ, Lee S. Toll-like receptors and inflammation in the CNS. Curr Drug Targets Inflamm Allergy 2002; 1: 181-91.
114. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav Immun 2003; 17: 13-9.
115. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006; 7: 1250-7.
116. Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006; 442: 39-44.
117. Van Amersfoort ES, Van Berkel TJ, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003; 16: 379-414.
118. Chamaillard M, Hashimoto M, Horie Y, et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003; 4: 702-7.
119. Girardin SE, Boneca IG, Carneiro LA, et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003; 300: 1584-7.
120. Tanabe T, Chamaillard M, Ogura Y, et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J 2004; 23: 1587-97.
121. Sterka D Jr, Marriott I. Characterization of nucleotide-binding oligomerization domain (NOD) protein expression in primary murine microglia. J Neuroimmunol 2006; 179: 65-75.
122. Sterka D Jr, Rati DM, Marriott I. Functional expression of NOD2, a novel pattern recognition receptor for bacterial motifs, in primary murine astrocytes. Glia 2006; 53(3): 322-30.
123. Husemann J, Silverstein SC. Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain. Am J Pathol 2001; 158: 825-32.
124. Alarcon R, Fuenzalida C, Santibanez M, von Bernhardi R. Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J Biol Chem 2005; 280: 30406-15.
125. Husemann J, Loike JD, Anankov R, Febbraio K, Silverstein SC. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 2002; 40: 195-205.
126. Peiser L, Mukhopadhyay S, Gordon S. Scavenger receptors in innate immunity. Curr Opin Immunol 2002; 14: 123-8.
127. Huang Y, Erdmann N, Peng H, Zhao Y, Zheng J. The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol Immunol 2005; 2: 113-22.
128. Soulas P, Woods A, Jaulhac B, et al. Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection. J Clin Invest 2005; 115: 2257-67.
129. Ryskova O, Vyslouzil L, Honegr K, Lesna J, Horacek J, Skrabkova Z. Lyme borreliosis-incidence of serum anti-myelin antibodies. Epidemiol Mikrobiol Imunol 2002; 51: 60-5.
130. Kaiser R. Intrathecal immune response in patients with neuroborrehosis: specificity of antibodies for neuronal proteins. J Neurol 1995; 242: 319-25.
131. Larsson C, Andersson M, Pelkonen J, Guo BP, Nordstrand A, Bergstrom S. Persistent brain infection and disease reactivation in relapsing fever borreliosis. Microbes Infect 2006; 8: 2213-9.
132. Nowalk AJ, Gilmore RD Jr, Carroll JA. Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect Immun 2006; 74: 3864-73.
133. Bykowski T, Babb K, von Lackum K, Riley SP, Norris SJ, Stevenson B. Transcriptional regulation of the Borrelia burgdorferi antigenically variable VlsE surface protein. J Bacteriol 2006; 188: 4879-89.
134. Livengood JA, Gilmore RD Jr. Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi. Microbes Infect 2006; 8: 2832-40
135. Pachner AR, Gelderblom H, Cadavid D. The rhesus model of Lyme neuroborreliosis. Immunol Rev 2001; 183: 186-204.
136. Gray F, Nordmann P. 1997. Bacterial infections. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology: infections. London: Arnold. p 113-156.
137. de Waal MR, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol 1992; 4: 314-20.
138. Ledeboer A, Breve JJ, Wierinckx A, et al. Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur J Neurosci 2002; 16: 1175-85.
139. Frei K, Lins H, Fontana A. Production and function of IL-10 in the central nervous system. Schweiz Arch Neurol Psychiatr 1994; 145: 30-1.
140. Lodge PA, Sriram S. Regulation of microglial activation by TGF-beta, IL-10, and CSF-1. J Leukoc Biol 1996; 60: 502-8.
141. Guo H, Jin YX, Ishikawa M, et al. Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines. Scand J Immunol 1998; 48: 502-8.
142. O'Keefe GM, Nguyen VT, Benveniste EN. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10. Eur J Immunol 1999; 29: 1275-85.
143. Ledeboer A, Breve JJ, Poole S, Tilders FJ, Van Dam AM. Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of proinflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia 2000; 30: 134-42.
144. Shrikant P, Weber E, Jilling T, Benveniste EN. Intercellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6. J Immunol 1995; 155: 1489-501.
145. Mizuno T, Sawada M, Marunouchi T, Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem Biophys Res Commun 1994; 205: 1907-15.
146. Flaris NA, Hickey WF. Development and characterization of an experimental model of brain abscess in the rat. Am J Pathol 1992; 141: 1299-307.
147. Scheifele DW, Daum RS, Syriopoulou VP, Averill DR, Smith AL. Haemophilus influenzae bacteremia and meningitis in infant primates. J Lab Clin Med 1980 Mar; 95: 450-62.
148. Tauber MG, Brooks-Fournier RA, Sande MA. Experimental models of CNS infections. Contributions to concepts of disease and treatment. Neurol Clin 1986; 4: 249-64.
149. Roberts ED, Bohm RP Jr, Lowrie RC Jr, et al. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 1998; 178: 722-32.
150. Pachner AR, Gelderblom H, Cadavid D. The rhesus model of Lyme neuroborreliosis. Immunol Rev 2001; 183: 186-204.
151. Marriott I. The role of tachykinins in central nervous system inflammatory responses. Front Biosci 2004; 9: 2153-65.
152. Hokfelt T, Pernow B, Wahren J. Substance P: a pioneer amongst neuropeptides. J Intern Med 2001; 249: 27-40.
153. Rasley A, Bost KL, Olson JK, Miller SD, Marriott I. Expression of functional NK-1 receptors in murine microglia. Glia 2002; 37: 258-67.
154. Khan NA, Kim Y, Shin S, Kim KS. FimH-mediated Escherichia coli K1 invasion of human brain microvascular endothelial cells. Cell Microbiol 2007; 9: 169-78.
155. Kim KS. Escherichia coli translocation at the blood-brain barrier. Infect Immun 2001; 69: 5217-22.
156. Babcock AA, Wirenfeldt M, Holm T, et al. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J Neurosci 2006; 26: 12826-37
157. Qin L, Li G, Qian X, et al. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Glia 2005; 52: 78-84.
158. Lehnardt S, Massillon L, Follett P, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 2003; 100: 8514-9.
159. Peiser L, De Winther MP, Makepeace K, et al. The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect Immun 2002; 70: 5346-54.